Aligos therapeutics announces clinical collaboration with xiamen amoytop biotech co., ltd.

Amoytop to sponsor a phase 1b exploratory clinical study evaluating the efficacy and safety of alg-000184 in combination with pegbing® (mipeginterferon alfa-2b) in chb patients

ALGS Ratings Summary

ALGS Quant Ranking